ChemoMetec Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 174

Employees

  • Stock Symbol
  • CHEMM

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $101.76
  • (As of Friday Closing)

ChemoMetec General Information

Description

ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells, as well as image analysis. The company operates in the following categories: instruments, consumables (which derive maximum revenue), services, and others. Geographically, it derives maximum revenue from the United States and Canada, followed by Europe and the Rest of the world.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Gydevang 43
  • 3450 Allerod
  • Denmark
+45 48
Primary Industry
Monitoring Equipment
Other Industries
Biotechnology
Stock Exchange
CSE
Corporate Office
  • Gydevang 43
  • 3450 Allerod
  • Denmark
+45 48

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChemoMetec Stock Performance

As of 13-Nov-2026, ChemoMetec’s stock price is $101.76. Its current market cap is $1.75B with 17.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$101.76 $101.66 $36.53 - $122.36 $1.75B 17.2M 68.5K $1.81

ChemoMetec Financials Summary

As of 30-Jun-2026, ChemoMetec has a trailing 12-month revenue of $79.8M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 921,781 921,781 1,558,366 728,470
Revenue 79,798 79,798 72,185 59,163
EBITDA 44,538 44,538 35,132 26,966
Net Income 31,515 31,515 25,446 19,768
Total Assets 131,521 131,521 131,943 97,138
Total Debt 701 701 1,007 596
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ChemoMetec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ChemoMetec‘s full profile, request access.

Request a free trial

ChemoMetec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting
Monitoring Equipment
Allerod, Denmark
174 As of 2026

Fremont, CA
 

Cincinnati, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChemoMetec Competitors (25)

One of ChemoMetec’s 25 competitors is Cytek Biosciences, a Formerly VC-backed company based in Fremont, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cytek Biosciences Formerly VC-backed Fremont, CA
Meridian Bioscience Private Equity-Backed Cincinnati, OH
10x Genomics Formerly VC-backed Pleasanton, CA
Aligned Genetics Formerly VC-backed Gunpo, South Korea
Bio-Techne Corporation Minneapolis, MN
You’re viewing 5 of 25 competitors. Get the full list »

ChemoMetec Patents

ChemoMetec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4416567-A1 Method for monitoring a liquid culture flow Active 14-Oct-2021
EP-4416567-B1 Method for monitoring a liquid culture flow Active 14-Oct-2021
EP-4416567-C0 Method for monitoring a liquid culture flow Active 14-Oct-2021
US-20240368523-A1 Method for monitoring a liquid culture flow Pending 14-Oct-2021
EP-4305197-A1 Assessment of biological particles immobilized in a hydrogel Pending 11-Mar-2021 C12Q1/6846
To view ChemoMetec’s complete patent history, request access »

ChemoMetec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChemoMetec Acquisitions (1)

ChemoMetec’s most recent deal was a Merger/Acquisition with Ovizio for . The deal was made on 22-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ovizio 22-Oct-2024 Merger/Acquisition Other Devices and Supplies
To view ChemoMetec’s complete acquisitions history, request access »

ChemoMetec ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

20.35 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 67

Rank

Percentile

To view ChemoMetec’s complete esg history, request access »

ChemoMetec Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Ovizio La Hulpe, Belgium 2009

ChemoMetec FAQs

  • When was ChemoMetec founded?

    ChemoMetec was founded in 1997.

  • Where is ChemoMetec headquartered?

    ChemoMetec is headquartered in Allerod, Denmark.

  • What is the size of ChemoMetec?

    ChemoMetec has 174 total employees.

  • What industry is ChemoMetec in?

    ChemoMetec’s primary industry is Monitoring Equipment.

  • Is ChemoMetec a private or public company?

    ChemoMetec is a Public company.

  • What is ChemoMetec’s stock symbol?

    The ticker symbol for ChemoMetec is CHEMM.

  • What is the current stock price of ChemoMetec?

    As of 13-Nov-2026 the stock price of ChemoMetec is $101.76.

  • What is the current market cap of ChemoMetec?

    The current market capitalization of ChemoMetec is $1.75B.

  • What is ChemoMetec’s current revenue?

    The trailing twelve month revenue for ChemoMetec is $79.8M.

  • Who are ChemoMetec’s competitors?

    Cytek Biosciences, Meridian Bioscience, 10x Genomics, Aligned Genetics, and Bio-Techne are some of the 25 competitors of ChemoMetec.

  • What is ChemoMetec’s annual earnings per share (EPS)?

    ChemoMetec’s EPS for 12 months was $1.81.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process